These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

220 related articles for article (PubMed ID: 28545141)

  • 21. Activation of microglia by retroviral infection correlates with transient clearance of prions from the brain but does not change incubation time.
    Muth C; Schröck K; Madore C; Hartmann K; Fanek Z; Butovsky O; Glatzel M; Krasemann S
    Brain Pathol; 2017 Sep; 27(5):590-602. PubMed ID: 27558169
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Loss of Homeostatic Microglia Signature in Prion Diseases.
    Wang Y; Hartmann K; Thies E; Mohammadi B; Altmeppen H; Sepulveda-Falla D; Glatzel M; Krasemann S
    Cells; 2022 Sep; 11(19):. PubMed ID: 36230910
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The role of the NADPH oxidase NOX2 in prion pathogenesis.
    Sorce S; Nuvolone M; Keller A; Falsig J; Varol A; Schwarz P; Bieri M; Budka H; Aguzzi A
    PLoS Pathog; 2014 Dec; 10(12):e1004531. PubMed ID: 25502554
    [TBL] [Abstract][Full Text] [Related]  

  • 24. SIRPα-Antibody Fusion Proteins Selectively Bind and Eliminate Dual Antigen-Expressing Tumor Cells.
    Piccione EC; Juarez S; Tseng S; Liu J; Stafford M; Narayanan C; Wang L; Weiskopf K; Majeti R
    Clin Cancer Res; 2016 Oct; 22(20):5109-5119. PubMed ID: 27126995
    [TBL] [Abstract][Full Text] [Related]  

  • 25. CD47 Protects Synapses from Excess Microglia-Mediated Pruning during Development.
    Lehrman EK; Wilton DK; Litvina EY; Welsh CA; Chang ST; Frouin A; Walker AJ; Heller MD; Umemori H; Chen C; Stevens B
    Neuron; 2018 Oct; 100(1):120-134.e6. PubMed ID: 30308165
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The interaction between signal regulatory protein alpha (SIRPα) and CD47: structure, function, and therapeutic target.
    Barclay AN; Van den Berg TK
    Annu Rev Immunol; 2014; 32():25-50. PubMed ID: 24215318
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Neuroinflammation in Prion Disease.
    Li B; Chen M; Zhu C
    Int J Mol Sci; 2021 Feb; 22(4):. PubMed ID: 33672129
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Prion encephalopathies of animals and humans.
    Prusiner SB
    Dev Biol Stand; 1993; 80():31-44. PubMed ID: 8270114
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Neuroinflammation, Microglia, and Cell-Association during Prion Disease.
    Carroll JA; Chesebro B
    Viruses; 2019 Jan; 11(1):. PubMed ID: 30650564
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Role of galectin-3 in prion infections of the CNS.
    Mok SW; Riemer C; Madela K; Hsu DK; Liu FT; Gültner S; Heise I; Baier M
    Biochem Biophys Res Commun; 2007 Aug; 359(3):672-8. PubMed ID: 17555713
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Cell adhesion molecule CD44 is dispensable for reactive astrocyte activation during prion disease.
    Bradford BM; Walmsley-Rowe L; Reynolds J; Verity N; Mabbott NA
    Sci Rep; 2024 Jun; 14(1):13749. PubMed ID: 38877012
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Phagocytic Activities of Reactive Microglia and Astrocytes Associated with Prion Diseases Are Dysregulated in Opposite Directions.
    Sinha A; Kushwaha R; Molesworth K; Mychko O; Makarava N; Baskakov IV
    Cells; 2021 Jul; 10(7):. PubMed ID: 34359897
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The Role of Glial Cells in Neurobiology and Prion Neuropathology.
    Hay A; Popichak K; Moreno J; Zabel M
    Cells; 2024 May; 13(10):. PubMed ID: 38786054
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Microglia and prion disease.
    Brown DR
    Microsc Res Tech; 2001 Jul; 54(2):71-80. PubMed ID: 11455614
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Dendritic cell SIRPα regulates homeostasis of dendritic cells in lymphoid organs.
    Washio K; Kotani T; Saito Y; Respatika D; Murata Y; Kaneko Y; Okazawa H; Ohnishi H; Fukunaga A; Nishigori C; Matozaki T
    Genes Cells; 2015 Jun; 20(6):451-63. PubMed ID: 25818708
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Activation and function of murine primary microglia in the absence of the prion protein.
    Pinheiro LP; Linden R; Mariante RM
    J Neuroimmunol; 2015 Sep; 286():25-32. PubMed ID: 26298321
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Transgenetic investigations of prion diseases of humans and animals.
    Prusiner SB
    Philos Trans R Soc Lond B Biol Sci; 1993 Feb; 339(1288):239-54. PubMed ID: 8097053
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Mechanisms of prion-induced neurodegeneration.
    Saá P; Harris DA; Cervenakova L
    Expert Rev Mol Med; 2016 Apr; 18():e5. PubMed ID: 27055367
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Transcriptomic responses to prion disease in rats.
    Herbst A; Ness A; Johnson CJ; McKenzie D; Aiken JM
    BMC Genomics; 2015 Sep; 16(1):682. PubMed ID: 26341492
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Autoimmune animal models in the analysis of the CD47-SIRPα signaling pathway.
    Murata Y; Saito Y; Kaneko T; Kotani T; Kaneko Y; Ohnishi H; Matozaki T
    Methods; 2014 Jan; 65(2):254-9. PubMed ID: 24091004
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.